CME Presentations

SSC-ILD


Presentations


Speakers

  • Amy Olson, MD, MSPH

    Amy Olson, MD, MSPH

    Amy Olson, MD, MSPH

    Associate Professor, Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine

    Amy L. Olson, MD, MSPH, is an associate professor of medicine at National Jewish Health and the University of Colorado in Denver. At National Jewish Health, she is a member of the Interstitial Lung Disease Clinic and Autoimmune Lung Center and is the medical director of the Pulmonary Physiology Unit. Dr. Olson earned her medical degree and Master of Science degree in public health at the University of Colorado, and completed her medical internship, residency, and pulmonary and critical care fellowship at the University of Colorado as well. Dr. Olson completed a fourth year of subspecialty training in Interstitial Lung Disease at the University of Washington in Seattle. Dr. Olson has authored a number of original research articles on the epidemiology of pulmonary fibrosis, including studies of mortality rates, seasonal variation, and comorbid conditions, and is currently working on new outcome measures for clinical trials. She has presented her research findings at both national and international meetings.
  • Virginia Steen, MD

    Virginia Steen, MD

    Virginia Steen, MD

    Professor, Chief, Division of Rheumatology, Director, Rheumatology Fellowship Program, Department of Medicine

    Virginia D. Steen, MD, is Professor of Medicine with Tenure and Rheumatology Fellowship Director at Georgetown University Medical Center, Washington. She is also Chief of the Rheumatology Division. Dr. Steen received her MD from University of Pittsburgh, residency in internal medicine at the University of Pennsylvania, Philadelphia, and a fellowship in rheumatology at the University of Pittsburgh where she was on faculty before coming to Georgetown in 1995. She has received many awards including the American College of Rheumatology Clinical Science Award in 1998, Scleroderma Doctor of the Year in 2010 and the Lifetime Achievement Award in 2014 from the National Scleroderma Foundation. She received the American College of Rheumatology Excellence in Investigative Mentor Award in 2012, and is a Master of the ACR. She is the chair of the Medical and Scientific Advisory Board of the Scleroderma Foundation. Dr Steen’s primary research interests have been focused on understanding the epidemiology and natural history of the Systemic Sclerosis. Her research has resulted in more than 200 publications many of which are seminal studies on risk factors and outcomes for lung involvement, auto-antibodies, and survival in Scleroderma. She has been very involved in clinical trials in Scleroderma and has been a participant of all 3 of the Scleroderma Lung Studies for interstitial lung disease. She has been the rheumatology representative for the IPF guidelines. She continues to participate in clinical trials for systemic sclerosis, including studies on pulmonary fibrosis.
  • Zulma Yunt, MD

    Zulma Yunt, MD

    Zulma Yunt, MD

    Assistant Professor, Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine

    Zulma Yunt, MD is an Assistant Professor of Medicine at National Jewish Health. She has been a faculty member in the Interstitial Lung Disease Program at National Jewish since 2012. Her clinical interests include idiopathic pulmonary fibrosis, connective tissue disease associated ILD, hypersensitivity pneumonitis, bronchiolitis, and vasculitis. She is a co-investigator in numerous clinical research programs within the group. Dr. Yunt attended medical school at Creighton University in Omaha, NE. She completed her internal medicine residency in 2008 at Yale University. Thereafter, she moved to Denver to train in Pulmonary and Critical Care at the University of Colorado. During her fellowship, she led basic science investigations aimed at understanding the link between angiogenesis and pathologic lung fibrosis. She also studied the role of lung macrophages in propagating pulmonary fibrosis after acute lung injury. Dr. Yunt’s current research focuses on biomarkers in ILD, particularly Krebs von den Lungen -6 (KL-6). She is also investigating HRCT as a diagnostic tool in myositis-associated ILD and antisynthetase syndromes.

CME Information

Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): The Importance of Early Diagnosis, Patient Centered Communication and Evidence Based Treatment


NJH LogoPQH Logo

Educational Objectives

Upon completion of the educational activity, participants should be able to:
  • Apply best practices in diagnosis based on clinical symptoms, pathophysiology and disease course of SSc-ILD.
  • Utilize evidence-based decision making in the selection of treatments for patients with SSc-ILD.
  • Apply strategies for longitudinal management of SSc-ILD using a multidisciplinary approach and patient-centered communication.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

The goal of this activity is to improve the awareness, knowledge, and competency of pulmonologists, rheumatologists, radiologists, dermatologists and primary care physicians in the diagnosis, treatment and a multidisciplinary approach to the longitudinal management of Systemic Sclerosis Interstitial Lung Disease (SSc-ILD).

AMA PRA Category 1 Credits

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

National Jewish Health designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest Policy:

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

Disclaimer

National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Faculty and Disclosure

Amy Olson, MD, MSPH
Associate Professor
Department of Medicine
Division of Pulmonary,
Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Virginia D. Steen, MD
Professor
Chief, Division of Rheumatology
Director,
Rheumatology Fellowship Program
Department of Medicine
Georgetown University
Washington, DC

Zulma Yunt, MD
Assistant Professor
Department of Medicine
Division of Pulmonary,
Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Amy Olson, MD discloses that she on an Advisory Board for Boehringer Ingelheim, on the Board of Directors for MedGraphics as well as a speaker for Boehringer Ingelheim, Genentech, PeerView, Pilot/France Foundation and Vindico. Amy also conducts research for Boehringer Ingelheim.

Virginia Steen, MD discloses that she is on an Advisory Board for Boehringer Ingelheim and a Consultant for Boehringer Ingelheim, CSL Behring and Eicos.

Zulma Yunt, MD discloses that she is a Speaker for Boehringer Ingelheim.

None of the following planners or reviewers have any relevant financial relationships to disclose: Amen Sergew, MD, Michael Mohning, MD, Andrea Harshman, MHA, CHCP, CMP-HC, Meghan Brenner, MA, Mandy Comeau, the patient featured in the video segment.

Instructions

In order to receive CME credits, participants must complete the pre-assessment questions, post-test, and program evaluation. Participants must also score 2 out of 3 on the posttest. Certificates will be distributed online at the conclusion of the activity.

For information about the accreditation of this program, please contact proed@njhealth.org.

NJH Privacy Policy

https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices

The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME).

We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.

If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities.

Technical Support: For any technical issues or issues with your CME Certificate, please contact RESInsightsLive.com at 877-394-1306 or at Support@RESInsightsLive.com.